Table 3. Risk factors for the composite outcome among patients with advanced chronic kidney disease.
Variables | Hazard Ratio (95% confidence interval) | p value |
---|---|---|
Diabetes mellitus | 1.53 (1.34–1.74) | <0.001 |
Hypertension | 1.26 (1.11–1.41) | <0.001 |
Diuretic use | 2.13 (1.88–2.41) | <0.001 |
KA use | 0.43 (0.38–0.49) | <0.001 |
Daily KA dosage (expressed as tablets)
b larger than 5.5 vs. Unsuitable dose |
0.61 (0.40–0.93) | 0.0225 |
bKA prescribed at less than 5.5 tablets daily is considered an unsuitable dose
Factors used in the Cox model: all covariates listed in Table 1
Abbreviations: KA, Ketoanalog